Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
192.22
+1.27 (0.67%)
Sep 21, 2026, 1:01 PM EDT - Market open
Revolution Medicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $225 → $265 | Buy | Maintains | $225 → $265 | +37.86% | Sep 21, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $251 | Buy | Maintains | $251 | +30.58% | Sep 16, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $315 | Buy | Maintains | $315 | +63.87% | Sep 14, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $215 → $230 | Buy | Maintains | $215 → $230 | +19.65% | Sep 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $255 | Buy | Initiates | $255 | +32.66% | Sep 10, 2026 |
| Jefferies | Jefferies | Buy Maintains $270 | Buy | Maintains | $270 | +40.46% | Sep 3, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $246 | Buy | Maintains | $246 | +27.98% | Sep 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.